A recent study showed that sacubitril/valsartan could ameliorate the dysfunction of the RyR2 complex and NCX1 complex, which suggesting that sacubitril/valsartan may improve SR Ca2+ mishandling and help reduce AF vulnerability23. This evidence concerns the gene SLC8A1 and atrial fibrillation.